Literature DB >> 27784893

Connective tissue diseases: Remission in SLE - are we there yet?

Eric F Morand1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27784893     DOI： 10.1038/nrrheum.2016.174

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

Review 1.  The need to define treatment goals for systemic lupus erythematosus.

Authors:  Kate Franklyn; Alberta Hoi; Mandana Nikpour; Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2014-07-22       Impact factor: 20.543

2.  Predictors of organ damage in systemic lupus erythematosus: the Hopkins Lupus Cohort.

Authors:  Michelle Petri; Sneha Purvey; Hong Fang; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-12

3.  Remission in systemic lupus erythematosus: durable remission is rare.

Authors:  Theresa R Wilhelm; Laurence S Magder; Michelle Petri
Journal:  Ann Rheum Dis       Date:  2016-08-24       Impact factor: 19.103

4.  Novel evidence-based systemic lupus erythematosus responder index.

Authors:  Richard A Furie; Michelle A Petri; Daniel J Wallace; Ellen M Ginzler; Joan T Merrill; William Stohl; W Winn Chatham; Vibeke Strand; Arthur Weinstein; Marc R Chevrier; Z John Zhong; William W Freimuth
Journal:  Arthritis Rheum       Date:  2009-09-15

5.  Prolonged remission in Caucasian patients with SLE: prevalence and outcomes.

Authors:  Margherita Zen; Luca Iaccarino; Mariele Gatto; Silvano Bettio; Linda Nalotto; Anna Ghirardello; Leonardo Punzi; Andrea Doria
Journal:  Ann Rheum Dis       Date:  2015-07-29       Impact factor: 19.103

6.  Lupus-specific health outcome measure for US patients: the LupusQoL-US version.

Authors:  M Jolly; A S Pickard; C Wilke; R A Mikolaitis; L-S Teh; K McElhone; L Fogg; J Block
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

7.  Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

Authors:  Ronald F van Vollenhoven; Marta Mosca; George Bertsias; David Isenberg; Annegret Kuhn; Kirsten Lerstrøm; Martin Aringer; Hendrika Bootsma; Dimitrios Boumpas; Ian N Bruce; Ricard Cervera; Ann Clarke; Nathalie Costedoat-Chalumeau; László Czirják; Ronald Derksen; Thomas Dörner; Caroline Gordon; Winfried Graninger; Frédéric Houssiau; Murat Inanc; Søren Jacobsen; David Jayne; Anna Jedryka-Goral; Adrian Levitsky; Roger Levy; Xavier Mariette; Eric Morand; Sandra Navarra; Irmgard Neumann; Anisur Rahman; Jozef Rovensky; Josef Smolen; Carlos Vasconcelos; Alexandre Voskuyl; Anne Voss; Helena Zakharova; Asad Zoma; Matthias Schneider
Journal:  Ann Rheum Dis       Date:  2014-04-16       Impact factor: 19.103

8.  Definition and initial validation of a Lupus Low Disease Activity State (LLDAS).

Authors:  Kate Franklyn; Chak Sing Lau; Sandra V Navarra; Worawit Louthrenoo; Aisha Lateef; Laniyati Hamijoyo; C Singgih Wahono; Shun Le Chen; Ou Jin; Susan Morton; Alberta Hoi; Molla Huq; Mandana Nikpour; Eric F Morand
Journal:  Ann Rheum Dis       Date:  2015-10-12       Impact factor: 19.103

Review 9.  Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.

Authors:  Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2015-05-12       Impact factor: 19.103
  9 in total
  3 in total

1.  Impact of follow-up visits on disease outcome in Chinese systemic lupus erythematosus.

Authors:  Huanhuan Ma; Jing Dong; Liqin Wang; Lei Zhao; Lin Pan
Journal:  Clin Rheumatol       Date:  2017-08-03       Impact factor: 2.980

2.  Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.

Authors:  Vera Golder; Rangi Kandane-Rathnayake; Alberta Yik-Bun Hoi; Molla Huq; Worawit Louthrenoo; Yuan An; Zhan Guo Li; Shue Fen Luo; Sargunan Sockalingam; Chak Sing Lau; Mo Yin Mok; Aisha Lateef; Kate Franklyn; Susan Morton; Sandra Teresa V Navarra; Leonid Zamora; Yeong-Jian Wu; Laniyati Hamijoyo; Madelynn Chan; Sean O'Neill; Fiona Goldblatt; Mandana Nikpour; Eric Francis Morand
Journal:  Arthritis Res Ther       Date:  2017-03-20       Impact factor: 5.156

3.  Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II study.

Authors:  Eric F Morand; David A Isenberg; Daniel J Wallace; Amy H Kao; Cristina Vazquez-Mateo; Peter Chang; Kishore Pudota; Cynthia Aranow; Joan T Merrill
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.